We are live on ! Find out more
RHE

Regional Health Properties, Inc.

Delisted

RHE was delisted on the 3rd of February, 2025.

15 hedge funds and large institutions have $348K invested in Regional Health Properties, Inc. in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more capital invested

Capital invested by funds: $153K → $348K (+$194K)

36% more funds holding

Funds holding: 1115 (+4)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
5
Closed
Calls
Puts
Net Calls
Net Calls Change

RHE Hedge Fund Activity: Q1 2023 in Review

15 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Regional Health Properties, Inc. (RHE) for Q1 2023, worth a combined $348K — up 127% from $153K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new RHE positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $110K. The largest seller was UBS Group, cutting an estimated $3.92K.

  • 15 institutional investors held Regional Health Properties, Inc. (RHE) as of Q1 2023, up from 11 in Q4 2022.
  • Funds reported $348K of Regional Health Properties, Inc. stock for Q1 2023, up 127% quarter-over-quarter.
  • 4 funds opened new Regional Health Properties, Inc. positions in Q1 2023 and 0 closed out, a net change of +4 holders.
  • The largest Regional Health Properties, Inc. buyer in Q1 2023 was Susquehanna International Group, an estimated $110K added.
  • The largest Regional Health Properties, Inc. seller in Q1 2023 was UBS Group, an estimated $3.92K sold.

Based on aggregated 13F filings for Q1 2023.